Literature DB >> 12566848

Trypanosoma cruzi: in vitro morphological alterations induced by actinomycin D.

Tânia Zaverucha do Valle1, Kátia S Calabrese, Suzana Côrte-Real, Wagner C Baetas, Sylvio C Gonçalves da Costa.   

Abstract

Actinomycin (ActD) is an antibiotic that binds DNA, preventing transcription. When a Trypanosoma cruzi infection in mice is treated with this drug, the parasite loses its ability to multiply, enabling protection. In this study, axenic cultured T. cruzi parasites were exposed to different concentrations of ActD (10, 20, and 50 microg/ml), all of them being able to inhibit growth and to alter the mobility. Nevertheless, the parasites remained alive and motile for at least 14 days. Scanning electron microscopy of trypomastigotes treated with 10 microg/ml of ActD for 24 h showed a modification in their morphology which suggests a change in the parasite cytoskeleton. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566848     DOI: 10.1159/000067741

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  1 in total

1.  Microsatellite and mini-exon analysis of Mexican human DTU I Trypanosoma cruzi strains and their susceptibility to nifurtimox and benznidazole.

Authors:  Ignacio Martínez; Benjamín Nogueda; Fernando Martínez-Hernández; Bertha Espinoza
Journal:  Vector Borne Zoonotic Dis       Date:  2013-02-19       Impact factor: 2.133

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.